InvestorsHub Logo
icon url

ADVFN_curncman

10/02/20 7:45 AM

#28799 RE: rrao11 #28798

Rao, Great Find by you and thanks for sharing the info. Yes Perfect additions to SAB at the right time is very important. Chris Mizer has great educational background in Medicine and very well connected with executives in fortune 500 Pharma Companies. So He will be very helpful in building much needed partnerships based on recurring royalty fees to bring steady flow of revenues into TSOI quarter-by-quarter.

Also Chris Mizer has published many research articles with our SAB Dr.Tom Ichim and VP of Business Development Ms.Famela Ramos, in area of immunotherapy which is rare combination to be a research associate and sales background to seal BIG deals in future for TSOI.
https://pubmed.ncbi.nlm.nih.gov/23171397/

Our time has come for TSOI to start making revenues month - by -month on NS, Nano Cannabidiol and QM to start with paving way for the TSOI PPS to breakout soon to over 10 cents with IND filings and Update on QUADRAMUNE Clinical Trial Phase II